Assessment of role Calcium Gluconate for early reversal of neuromuscular blockade in Children after surgery
Not Applicable
- Conditions
- Health Condition 1: null- healthy patients in ASA (American Society of Anaesthesiology)I or II undergoing surgery
- Registration Number
- CTRI/2018/03/012386
- Lead Sponsor
- AIIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
(a) Children between the age group of 05 year
to 15 yrs
(b) ASA I and II
Exclusion Criteria
(a)Suspected difficult airway
(b)History of bronchial asthma, neuromuscular disease or hepatic and renal disease.
(c)Patient taking any medication known to influence the potency or duration of neuromuscular blocking agents.
(d)Hypercalcemia
(e)History of malignant hyperthermia, allergies to glycopyrrolate or neostigmine
(f)Severe and significant congenital heart disease
(g)Bleeding diathesis
(h)Parental refusal
(i)Weight < 10 kilogram
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary end point will be neuromuscular recovery time (time from reversal administration to recovery of the TOF ratio to 0.9) <br/ ><br>Timepoint: 1
- Secondary Outcome Measures
Name Time Method Secondary end points will incude the TOFr at 5, 10,and 20 min after reversal administration and the incidence of PORC at each time point.Timepoint: 3